Trial Details

Not Recruiting
Basic Information
Clinical ID c2264
Identifier EUCTR2022-000875-37-IT
Trial Title A Prospective, Randomized, Placebo-controlled Clinical Trial of oral vancomycin in adults and young adults (15-17 years old) affected by Primary Sclerosing Cholangitis with or without Inflammatory Bowel Disease - Vancomycin in Primary Sclerosing Cholangitis in Italy
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Primary Sclerosing Cholangitis MedDRA version: 20.1_Level: LLT_Classification code 10036732_Term: Primary sclerosing cholangitis_System Organ Class: 100000004871_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: LEVOVANOX Product Name: LEVOVANOX Product Code: [LEVOVANOX] Pharmaceutical Form: Capsule, hard INN or Proposed INN: VANCOMICINA CLORIDRATO Current Sponsor code: VANCOMICINA Concentration unit: mg milligram(s) Concentration type: up to Concentration number: 1500- Pharmaceutical form of the placebo: Capsule, hard Route of administration of the placebo: Oral use
Participant Information
Sponsor UNIVERSITÀ DEGLI STUDI MILANO BICOCCA
City -
Country/Region Italy
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -